TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Santos, C.
Lawrence, P.
Lopez-Doriga, A.
Ragulan, C.
Fontana, E.
Desai, K.
Ps, H.
Elez Fernandez, M. E.
Aranda Aguilar, E.
Losa, F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier